Royalty Pharma plc (RPRX)
NASDAQ: RPRX · Real-Time Price · USD
37.17
+0.50 (1.36%)
Oct 30, 2025, 11:29 AM EDT - Market open
Royalty Pharma Employees
Royalty Pharma had 99 employees as of December 31, 2024. The number of employees increased by 10 or 11.24% compared to the previous year.
Employees
99
Change (1Y)
10
Growth (1Y)
11.24%
Revenue / Employee
$23,285,283
Profits / Employee
$10,310,364
Market Cap
21.68B
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 99 | 10 | 11.24% |
| Dec 31, 2023 | 89 | 14 | 18.67% |
| Dec 31, 2022 | 75 | 9 | 13.64% |
| Dec 31, 2021 | 66 | 15 | 29.41% |
| Dec 31, 2020 | 51 | 16 | 45.71% |
| Dec 31, 2019 | 35 | - | - |
Sources: Annual number of employees according to filings submitted to the U.S. Securities and Exchange Commission (SEC). Data is also manually gathered from company press releases, IPO filings, and other official sources.
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 92,900 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
RPRX News
- 13 days ago - Royalty Pharma Declares Fourth Quarter 2025 Dividend - GlobeNewsWire
- 20 days ago - Royalty Pharma to Announce Third Quarter 2025 Financial Results on November 5, 2025 - GlobeNewsWire
- 4 weeks ago - Royalty Pharma Appoints Dr. Ted W. Love As Lead Independent Director - GlobeNewsWire
- 5 weeks ago - Royalty Pharma plc (RPRX) Presents at Bernstein Insights: Healthcare Leaders and Disruptors - 2nd Annual Healthcare Forum Transcript - Seeking Alpha
- 5 weeks ago - Royalty Pharma to Present at Bernstein's 2nd Annual Healthcare Forum - GlobeNewsWire
- 6 weeks ago - Royalty Pharma: Investor Day Upside - Seeking Alpha
- 6 weeks ago - Royalty Pharma Plc (RPRX) Investor Day 2025 Call (Transcript) - Seeking Alpha
- 7 weeks ago - Royalty Pharma Investor Day Highlights Strong Growth Outlook and Company's Plans to Drive Value Creation - GlobeNewsWire